|
Volume 272, Number 13,
Issue of March 28, 1997
pp. 8759-8763
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Novel Characteristics of a Myosin Isolated from Mammalian Retinal
Pigment Epithelial and Endothelial Cells*
(Received for publication, August 22, 1996, and in revised form, November 22, 1996)
Mark C.
Alliegro
and
Laura A.
Linz
From the Department of Anatomy, Louisiana State University Medical
Center, New Orleans, Louisiana 70112
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
ABSTRACT
We have isolated a novel, high
Mr protein from human retinal pigment
epithelial cells and endothelial cells by affinity chromatography on
Sepharose 4B. Two polypeptides are present on SDS-gels of the 8 M urea eluent with apparent molecular mass of ~210 and 47 kDa. In the absence of dithiothreitol, the two polypeptides migrate as
one protein band with an apparent molecular mass of ~550 kDa. "Piglet," as this molecule is tentatively named, is present in retinal pigment epithelial and endothelial cells of several species, but could not be detected in the nonepithelial cells we examined. Immunofluorescent localization using an antibody to the 210-kDa polypeptide revealed a filamentous network in the cytoplasm of cultured
cells. This antibody was used to identify a cDNA for piglet in a
bovine aortic endothelial cell expression library. Sequence data
indicate a high degree of identity with non-muscle myosin II heavy
chain. We subsequently found that piglet had an actin-activated ATPase
activity, colocalized with actin in cells, and reacted on Western blots
with a pan-non-muscle myosin II heavy chain antiserum. The protein was
also recognized by antibodies specific for myosin heavy chain isoform
A, but did not react with anti-isoform B antibodies. Although piglet
has several features in common with known forms of non-muscle myosin
II, the distinctly unconventional features it displays suggest that it
is a novel myosin.
INTRODUCTION
The retinal pigment epithelium (RPE)1
is composed of a population of cuboidal to low columnar cells
sandwiched between the neural retina and the highly vascularized
choroid layer of the eye. Although RPE cells are normally
nonproliferative and nonmigratory, they are highly active in other
respects. They are indespensible for the function and survival of their
immediate neighbors, the rods and cones, and malfunctions in the RPE
form the basis for a variety of blinding disorders.
The RPE cell feature that is perhaps most directly related to vision is
the presence of dense pigment granules in their cytoplasm. These
granules absorb light that has passed through the neural layers of the
retina, preventing backscatter and unwanted reflection. The RPE also
performs a variety of metabolic functions in support of the neural
retina. By means of tight junctions, they create the blood-ocular
barrier that regulates the passage of molecules between the retina and
choroidal capillaries (1). They are, therefore, primary determinants of
the photoreceptor microenvironment. The RPE is also responsible for
phagocytosis and disposal of shed photoreceptor outer segments (2). In
the absence of this function, degeneration of the neural retina ensues.
Moreover, RPE are essential for production of the visual pigment
rhodopsin (3). During the visual cycle, the
11-cis-retinaldehyde chromophore of rhodopsin present in
photoreceptor cells is reduced to all-trans-retinol. To
regenerate rhodopsin, the spent product is transferred to the RPE where
it is isomerized to the 11-cis form once again. Directly and
indirectly, therefore, the RPE is essential for vision.
As in all cellular systems, carbohydrate recognition molecules are
thought to figure prominently in RPE physiology (and pathophysiology). For example, a mannose receptor present in the RPE plasma membrane has
been shown to mediate phagocytosis of rod outer segments (4). Also,
changes in the expression of specific carbohydrate moieties accompanying retinal pathology have been demonstrated in lectin binding
studies (5, 6). However, identification of endogenous retinal lectins
and delineation of the specific roles they play have been elusive. In
the case of galactose-binding proteins, a useful method of isolation
from cell homogenates is affinity chromatography on unconjugated
Sepharose 4B (for examples, see Vasta and Marchalonis (7) and Alliegro
et al. (8)). Sepharose, being a trade name for agarose, is a
linear polymer of D-galactose and 3,6-anhydrogalactose. We
have used this approach to identify and isolate carbohydrate binding
molecules from mammalian RPE, and this report describes the isolation
and initial characterization of one such protein, called piglet (for
pigment epithelial lectin). Piglet is a high Mr
oligomeric protein that binds avidly to Sepharose and displays several
hallmark features of cytoplasmic myosin. Our data suggest that piglet
is a new member of the growing myosin superfamily.
MATERIALS AND METHODS
Cell Culture
Reagents for cell culture were purchased from
Life Technologies, Inc. and Sigma. Cells were cultured under routine
conditions in minimal essential medium plus 15% fetal bovine serum and
100 units/ml penicillin + 100 µg/ml streptomycin (MEM-15). All cell types not purchased from American Type Culture Collection (Rockville, MD) were isolated using methods described previously (9), except D407
RPE cells (10), which were generously provided by Dr. Alberta Davis.
Protein Isolation and Characterization
Cells were harvested
mechanically from Nunc (Milwaukee, WI) Delta-Square culture trays or
T175 flasks after two or three rinses in ice-cold PBS. They were washed
three additional times by centrifugation and resuspension in cold PBS,
transfered to microcentrifuge tubes, and pelleted for 2 min at maximum
speed, decanted, and frozen until approximately 8 ml of packed cells
were accumulated. The thawed cells were pooled, homogenized, and
sonicated in 50 mM Tris, pH 7.5, containing 1% Triton
X-100, 7 mM EDTA, and 1% Me2SO. The homogenate
was centrifuged at 30,000 × g for 45 min, and the supernatant was applied to a 1.5 × 2-cm column of Sepharose 4B at
4 °C. For convenience and maximum yield, the sample was usually cycled on the column overnight. To reduce the chances of nonspecific binding or precipitation within the column, the sample volume was
doubled with homogenization buffer prior to affinity chromatography (halving overall protein concentration), and the column itself was
preequilibrated with homogenization buffer. Following sample application the column was washed with at least 25 volumes of 50 mM Tris, 1% Triton, pH 7.5, then 50 volumes of 50 mM Tris, 1 M NaCl, and eluted with 8 M urea in 50 mM Tris.
For ATPase assays, fractions were pooled and dialyzed extensively in 50 mM Tris, pH 7.5, to remove urea. Samples were then concentrated by acetone or trichloroacetic acid precipitation, lyophilized, and resuspended in assay buffer. ATPase activity was
determined in the presence of 4 mM MgCl2 using
methods described by Heinonen and Lahti (11). The phenol-sulfuric acid
assay was used for estimation of carbohydrate (12). Deglycosylation
experiments using neuraminidase, and O- and
N-glycosidases alone and in combination were carried out as
described by Matherly et al. (13). Glycosidases were
purchased from Genzyme (Cambridge, MA).
Routine SDS-gel electrophoresis was performed according to the methods
of Laemmli (14). Gradient gels were prepared using the manufacturer's
suggestions accompanying Hoeffer (San Francisco, CA) gradient makers.
Mr estimates under nonreducing conditions were
made using the buffer system of Davies and Stark (15). Dimethyl
suberimidate cross-linked standards for estimation of high
Mr proteins were purchased from Sigma.
Immunological Methods
For antibody production, purified
piglet was resolved into and subunits on SDS-polyacrylamide
gels. The subunit was excised, periodate-treated to disrupt
carbohydrate epitopes (16), and used to immunize female New Zealand
White rabbits. Antibodies to platelet myosin and isoform-specific
antibodies to non-muscle myosin II heavy chain (NMMHC) were gifts of
Dr. Robert Adelstein. Anti-actin was purchased from Sigma. Western blot
techniques were performed as described by Towbin et al.
(17). For immunocytochemistry, cells grown on sterile coverslips were
fixed in 2.5% paraformaldehyde for 5 min, followed by 3 min in 0.5%
Triton X-100 and 8 min in methanol at 20 °C. We found that
antigenicity was greatly reduced using formaldehyde or gluteraldehyde
fixatives. Primary antiserum was used at a dilution of 1/500 to 1/1000
in PBS plus 1.5% normal goat serum. Labeled specimens were viewed with
a Leica (Heidelberg, Germany) confocal laser scanning microscope.
cDNA Analysis
A bovine endothelial cell (EC) cDNA
library in -zap was obtained from Stratagene (La Jolla, CA) and
screened with -piglet antibodies according to standard methodologies
(18). Nested, unidirectional deletions were prepared from cesium
chloride-purified plasmid DNA using the Promega (Madison, WI)
Erase-a-Base sytem. Sequenase Version 2.0 (U. S. Biochemical Corp.,
Cleveland, OH) was used in cDNA sequencing. Sequences were
assembled and analyzed using IBI (New Haven, CT) MacVector software.
Sequence data base inquiries were made using the BLAST E-mail server
(19).
RESULTS
Isolation of Sepharose-binding Polypeptides from RPE and
EC
Following extensive detergent and high salt washes, RPE
protein retained on the Sepharose column was eluted with 8 M urea in a single, symmetrical peak. Recovery approximated
1 mg/8 ml packed cells. This yield seems to decrease with increasing
passage of cells. When peak fractions were analyzed on Coomassie
blue-stained SDS-gels, two polypeptides were observed (Fig.
1) migrating with apparent molecular mass of 210 and 47 kDa.2 Both polypeptides aggregated at the
stack/running gel interface in the absence of reducing agents. Gradient
and low percentage acrylamide gel formats were used to resolve the
aggregate as a single band with a molecular mass of 500-550 kDa,
suggesting that the two polypeptides observed on reducing gels are
subunits of one larger protein. Given the size of the individual
subunits and their relative molar ratios estimated from gels, it is
likely that the disulfide-bonded holoprotein is composed of two (210 kDa) and two (47 kDa) subunits.
Fig. 1.
RPE protein recovered from Sepharose 4B
column with 8 M urea. A, elution profile;
B, SDS-gel electrophoresis of the peak fraction in the
presence (+) and absence ( ) of dithiothreitol. Panel 1 in
B, Coomassie blue-stained 7.5% polyacrylamide; panel 2, 3-10% polyacrylamide gradient. Migration of selected
molecular mass markers are indicated by arrows.
[View Larger Version of this Image (27K GIF file)]
Results of phenol-sulfuric acid assays yielded variable estimates for
carbohydrate associated with the protein, ranging from 5 to 20%.
However, we found that exhaustive glycosidase treatment did not alter
migration in SDS-gels, so carbohydrate detected in the above assays may
not be covalently bound. The protein has been tentatively named
"piglet" for pigment epithelial lectin, but
monosaccharide specificity has not yet been determined.
Piglet Distribution
Piglet was also isolated in similar
quantities from bovine aortic EC. An additional polypeptide of 55 kDa
was present in these preparations, which did not aggregate with
oligomeric piglet in the absence of reducing agents. The two polyclonal
antibodies generated against the subunit of RPE piglet recognized
EC piglet. The one antibody generated against EC piglet also recognized
the RPE protein with equal avidity. These antibodies were used to survey a panel of other cell types for piglet expression (Fig. 2). Although present in RPE and EC from several species,
immunoreactivity was not readily detected in any of the mesenchymal
cell types examined (human and rabbit fibroblasts, human astrocytes,
human glioma, and mouse myeloma). In a nonsystematic survey of
available tissues, -piglet was identified by Western blot in cat
spleen, lung, and liver; bovine eye and kidney; mouse spleen, lung,
eye, kidney, brain, and liver; and rat spleen, lung, eye, and placenta. Piglet was not detected in rat liver.
Fig. 2.
Cell type-specific expression of piglet.
Thirty-five micrograms of total cellular protein were separated on a
7.5% SDS-polyacrylamide gel, transferred to nitrocellulose, and probed with a polyclonal antibody directed against the polypeptide moiety of
the piglet 210-kDa subunit. Left, Coomassie blue stain;
right, immunoblot using antiserum diluted at 1/1000.
Lanes 1, Mr standards; lanes
2-4, monkey, pig, and human RPE; lanes 5, fetal bovine
aortic EC; lanes 6, human astrocytes; lanes 7,
adult bovine aortic EC; lanes 8, human choroidal capillary
EC; lanes 9, mouse myeloma; lanes 10, human
fibroblasts.
[View Larger Version of this Image (103K GIF file)]
Piglet immunoreactivity was greatly affected by fixation and
histological preparation. Consistent labeling of cultured cells was
obtained with relatively mild paraformaldehyde fixation followed by
Triton and methanol permeabilization, as described under "Materials and Methods." Under these conditions, immunofluorescent confocal microscopy revealed a cytoplasmic, filamentous pattern of staining (Fig. 3). In human RPE the filaments appeared fine and
highly woven. In EC the filaments were more prominent, resembling
stress fibers. Filaments were most pronounced in the transformed RPE cell line, D407, and often exhibited a banded pattern (see Fig. 5).
Regardless of cell type, method of detection, or precise dimensions, filaments were the common theme. Identical patterns were observed with
all three anti-piglet antibodies in double label
immunofluorescence.
Fig. 3.
Confocal immunofluorescent localization of
piglet in cultured human RPE (A), and fetal bovine aortic
EC (B). C is a higher magnification view of
piglet's fibrillar arrangement in the border region of a well spread
fetal bovine aortic EC. Bar = 10 µm.
[View Larger Version of this Image (53K GIF file)]
Fig. 5.
Colocalization of piglet with actin in D407
(human RPE) cells. A, confocal immunofluorescent micrograph
showing piglet distribution; B, actin distribution.
Arrows highlight actin-containing filopodia that are devoid
of anti-piglet staining. Bar = 10 µm.
[View Larger Version of this Image (87K GIF file)]
Piglet Is a Myosin-like Molecule
Concurrent with these
findings, we obtained a partial sequence of 1142 base pairs on piglet
from a bovine cDNA clone ( -piglet 1.3) identified with our
anti-piglet antibodies. Nucleotide and predicted amino acid sequences
are shown in Fig. 4. The sequence shows 92% identity
with the C terminus of human NMMHC. A five-amino acid (ARAAE) extension
is present on the predicted C terminus of piglet. Interestingly, piglet
exhibits a 67-nucleotide domain in the presumptive 3 -UTR with 65%
identity to rat Munc-18, a mammalian homologue of the
Caenorhabditis elegans unc-18 gene (20, 21).
Unc-18 (for "uncoordinated") mutations lead to a paralytic phenotype, presumably due to a failure in acetylcholine release. The 3 -UTR for certain proteins, such as actin, are thought to
be important for subcellular localization of message (as well as
determining message stability). Functional implications for this
similarity between the piglet and Munc-18 3 -UTRs would be purely speculative at this point.
Fig. 4.
Partial nucleotide and deduced amino acid
sequence of -piglet (clone 1.3) from adult bovine aortic EC.
Nucleotide position is indicated on left, amino acids on
right. The termination codon, TAA, is
underlined.
[View Larger Version of this Image (84K GIF file)]
The observed sequence identity with NMMHC was congruent with the
subcellular localization just described, but other features of piglet
were clearly at odds with characteristics thought typical of myosins.
We therefore tested the notion that piglet is a myosin using several
approaches. We first posed the question of whether piglet is
co-distributed in cells with the actin cytoskeleton. Using the
transformed human RPE cell line, D407, and polyclonal anti-mammalian
actin antibodies, we found that this was indeed the case (Fig.
5). Actin was found, as expected, in prominent stress
fibers, extending into filopodia, and in a diffuse cytoplasmic pool.
Anti-piglet labeled RPE with an identical pattern, with the exception
that a subpopulation of fine actin-containing filopodia seemed to be
devoid of piglet immunoreactivity.
We next determined that purified piglet contains an actin-activated
ATPase activity, a hallmark of myosin. We used commercially available
skeletal muscle myosin as a positive control in a colorimetric phosphomolybdate assay for inorganic orthophosphate (11). One unit of
activity was defined as A495 nm of
0.001/min. Specific activity varied greatly between preparations, but
our consistent finding was that piglet exhibited at least as much activity as the myosin control: 215 ± 80.5 units/mg piglet
versus 103 ± 32.7 units/mg for the myosin control.
This considerable activity relative to the myosin control hedges
against the possibility that the ATPase activity in our piglet
preparations was due to contaminating trace quantities of a
conventional RPE myosin. Addition of actin (0.825 µg/µl) increased
the piglet activity by 3.3-fold; myosin activity was increased by
2-fold. These figures are comparable to the levels of actin activation
reported previously in the literature for a variety of myosin isoforms
(for examples, see Refs. 22-24). The quantities of purified protein
available did not permit a more extensive characterization of the
piglet ATPase activity, particularly with regard to cation
dependence.
NMMHC has been shown to exist in A and B isoforms (25-28). While often
found in the same cell, these isoforms are transcribed by separate
genes and may exhibit distinct subcellular localization patterns (29,
30). Isoform-specific antibodies have been generated by several
laboratories and used in the analysis of NMMHC from a variety of
species. In addition to its recognition by broad-specificity antibodies
generated against platelet-derived NMMHC (Fig. 6,
lane 2), we have found that piglet reacts avidly with
antibodies to NMMHC-A isoform. The antibody used in lane 3 of Fig. 6 is a polyclonal antibody generated against a 12-amino acid
cassette found specifically in NMMHC-A. Piglet did not react with
isotype B-specific antibodies, nor with antibodies to myosins V, VIIa,
and IXb. The latter three are widely expressed "unconventional"
myosins and comparable in molecular mass to piglet (190, 240, and 230 kDa, respectively) (31). It has been shown previously that myosin VIIa
is expressed in mammalian RPE (32). Lastly, it should be noted that
anti-piglet antibodies reacted poorly or not at all with NMMHC-A in
rabbit (not shown) or human fibroblasts (Fig. 6B,
lanes 1-4; also see Fig. 2).
Fig. 6.
A, immunoreactivity of piglet with
anti-NMMHC antibodies; 1 µg of protein/lane. Lane 1,
muscle myosin probed with an anti-NMMHC antibody of broad specificity;
lane 2, piglet probed with the same antibody; lane
3 piglet probed with antibody specific for NMMHC-A; lane
4, piglet probed with antibody specific for NMMHC-B. B,
cross-reactivity of three anti-piglet antisera with fibroblast NMMHC-A;
50 µg of total fibroblast protein/lane. Lane 1,
anti-NMMHC-A; lanes 2-4, anti-piglet. Lane 4 antiserum was used in library screening.
[View Larger Version of this Image (66K GIF file)]
DISCUSSION
The first molecular motor to be discovered was conventional,
two-headed myosin II. Because of its quantity and easy recognition in
muscle cells and its importance in cellular contraction, myosin II has
been extensively studied and well characterized at the molecular and
biophysical levels. Not long after the finding that myosins II were
present in non-muscle cells, Acanthamoeba myosin-I was
identified as the first "unconventional" myosin. Since then, and
particularly in the last few years, the field has blossomed with the
discovery of approximately two score of unconventional myosins and the
realization that even "conventional" myosin II comes in a variety
of flavors. It has also become apparent that multiple classes of myosin
may be expressed in a single cell type. Bement et al. (33),
for example, used a polymerase chain reaction approach to amplify 11 separate myosins in the human epithelial cell line
Caco2BBe.
A nomenclature system is just now beginning to take shape. The
"myosin superfamily" is currently divided into 11 classes, some
with several subclasses (31). Although no sequence data are available
for at least two of the newly identified myosins (24, 34) and full
sequence is available for only a limited number, several consensuses
have emerged. All of these molecules include a relatively conserved
N-terminal head domain within which lies the motor activity. There are
possible exceptions, such as the Drosophila class III
myosin, ninaC (31). The neck region of all known myosins
contain a variable number of ~23-amino acid repeats known as the IQ
motif. This domain is the putative site of light chain binding.
Following the neck domain is the carboxyl-terminal tail region, which
is generally the site of highest variability between myosin classes. In
myosins II, the tail region consists primarily of coiled coil -helix
thought to permit dimer and filament formation. In other myosin classes
the tail may be truncated and unsuitable for dimerization, or contain
sites for membrane binding or signal transduction.
Our initial conception of RPE piglet was as a disulfide-bonded,
oligomeric, carbohydrate-binding glycoprotein. We were mildly surprised
to find the protein distributed intracellularly as a filamentous
network, and sequence homology with myosin II was thoroughly
unexpected. We therefore carefully reviewed and confirmed our existing
data reflecting the distinctly "unmyosin-like" characteristics of
piglet. First, we repeatedly found that piglet bound to Sepharose 4B
and withstood extensive detergent and high salt washes. We subsequently
learned that a significant portion of the bound protein withstood even
8 M urea. This was determined by binding radioiodinated piglet to Sepharose in small batch preparations, eluting with 8 M urea, and then boiling the Sepharose resin prior to
SDS-gel electrophoresis. More than 50% of the bound protein was
recovered in the last step. In contrast, conventional myosin is often
sieved through large preparative Sepharose 4B columns as a
final separation from actin (see Refs. 22, 23, and 35 for examples).
Second, on SDS-gels in the absence of reducing agents, piglet seems to migrate as a heterotetramer with 210- and 47-kDa
subunits.3 We were not aware of any myosins
known to participate in disulfide bond formation. Third, piglet tested
positive for carbohydrate in our phenol-sulfuric acid assays. Neither
were we aware of any glycoprotein myosins. However, as mentioned
earlier, two observations serve to qualify the notion of covalently
bound carbohydrate; the variable results we obtained suggesting that
piglet was anywhere from 5% to >20% carbohydrate by mass, and our
inability to change the relative migration of piglet in SDS-gels
following extensive glycosidase treatment. Since mobility of the subunit alone was monitored (by Western blot), it is still possible
that the 47-kDa subunit contains a carbohydrate moiety.
Regardless of piglet's status as a glycoprotein, the first two
"unmyosin-like" features described above were enough to prompt further analyses along these lines. We therefore directed our subsequent studies at determining if piglet exhibited other features that were diagnostic of myosin. We found that piglet was co-distributed in cells with actin filaments, and that the molecule exhibited actin-enhanced ATPase activity and reacted avidly with antibodies to
platelet myosin as well as the isoform-specific C-terminal domain of
NMMHC-A. In the latter case, it should be noted that NMMHC-A is
reportedly 15 kDa smaller than piglet and is expressed in fibroblasts
(28), whereas piglet is not. These observations suggest to us that
piglet is a new, unconventional myosin.
Like so many of the newly discovered myosins, piglet's function in RPE
cell behavior is not yet known. There is, in fact, much to be uncovered
concerning the cytoskeletal organization of RPE in general. For
example, an intermediate filament network composed of cytokeratins 8 and 18 is thought to be diagnostic of RPE among other retinal cells,
but vimentin is known to be expressed in the RPE of at least two
vertebrate species thus far (chicken and cow) (36). The desmosomal and
zonulae adherens protein, plakoglobin, has been identified in RPE of
all species examined. However, desmoplakin and desmoglein are not
expressed in chicken or rat RPE (36). Whether these differences
represent diversity of function or conserved function accomplished by
different but related molecules is not clear. Of the unconventional
myosins, VIIa is known to be expressed in the RPE (31). A defective
myosin VIIa gene is thought to be responsible for Usher syndrome,
characterized by hearing impairment and retinitis pigmentosa (32, 37).
These studies demonstrate a crucial role for at least one myosin
isoform in RPE function, most likely in rod outer segment phagocytosis. A great deal remains to be learned about the molecular scaffolding and
motors involved in phagocytosis of shed photoreceptor outer segments,
retinaldehyde transport, and pigment granule organization, to mention
just a few vital RPE functions. As we discover more about the component
proteins of the RPE cytoskeleton, these processes are likely to be
detailed in the near future.
FOOTNOTES
*
This work was supported by National Institutes of Health
Grant EY09533 and by a grant from the Louisiana State University Neuroscience Center (to M. C. A.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) U87265[GenBank].
To whom correspondence should be addressed: Dept. of Anatomy,
Louisiana State University Medical Center, 1901 Perdido St., New
Orleans, LA 70112. Tel.: 504-568-7618; Fax: 504-568-4392; E-mail:
mallie{at}lsumc.edu.
1
The abbreviations used are: RPE, retinal pigment
epithelium; NMMHC, non-muscle myosin II heavy chain; EC, endothelial
cell; UTR, untranslated region.
2
A third polypeptide in these preparations, found
in trace quantities and observable only on silver-stained gels, has
been described in another report (38).
3
After identifying piglet as a myosin, we
examined the possibility that the 47-kDa " subunit" was
co-isolated actin. However, the 47-kDa band did not react on Western
blots with broad specificity anti-actin. The same antibody used to
co-localize piglet with actin by immunohistochemistry was used for
these blots.
ACKNOWLEDGEMENTS
We thank Dr. Robert Adelstein (National
Institutes of Health) and Dr. Mark Mooseker (Yale University) for
extremely helpful discussion and the use of their myosin antibodies.
Dr. Tama Hasson (Yale) processed our anti-myosin V, VIIa, and IXb
Western blots. Assistance from Mary Anne Alliegro with this project is
also greatly appreciated.
REFERENCES
-
Flannery, J. G., O'Day, W., Pfeffer, B. A., Horwitz, J., and Bok, D.
(1990)
Exp. Eye Res.
51,
717-728
[CrossRef][Medline]
[Order article via Infotrieve]
-
Young, R. W., and Bok, D.
(1969)
J. Cell Biol.
42,
392-403
[Abstract/Free Full Text]
-
Dowling, J. E.
(1960)
Nature
188,
114-118
[CrossRef][Medline]
[Order article via Infotrieve]
-
Boyle, D., Tien, L., Cooper, N., Shepard, V., and McLaughlin, B. J.
(1991)
Investig. Ophthalmol. Vis. Sci.
32,
1464-1470
[Abstract/Free Full Text]
-
Clark, V.
(1991)
Investig. Ophthalmol. Vis. Sci.
32,
327-335
[Abstract/Free Full Text]
-
Tien, L., McLaughlin, B. J., and Cooper, N. G.
(1991)
Investig. Ophthalmol. Vis. Sci.
32,
319-325
[Abstract/Free Full Text]
-
Vasta, G. R., and Marchalonis, J. J.
(1986)
J. Biol. Chem.
261,
9182-9186
[Abstract/Free Full Text]
-
Alliegro, M. C., Burdsal, C. A., and McClay, D. R.
(1990)
Biochemistry
29,
2135-2141
[CrossRef][Medline]
[Order article via Infotrieve]
-
Fenselau, A., and Mello, R. J.
(1976)
Cancer Res.
32,
3269-3273
-
Davis, A. A., Bernstein, P. S., Bok, D., Turner, J., Nachtigal, M., and Hunt, R. C.
(1995)
Investig. Ophthalmol. Vis. Sci.
36,
955-964
[Abstract/Free Full Text]
-
Heinonen, J. K., and Lahti, R. J.
(1981)
Anal. Biochem.
113,
313-317
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ashwell, G.
(1966)
Methods Enzymol.
8,
85-95
-
Matherly, L. H., Angeles, S. M., and Czajkowski, C. A.
(1992)
J. Biol. Chem.
267,
23253-23260
[Abstract/Free Full Text]
-
Laemmli, U. K.
(1970)
Nature
227,
680-685
[CrossRef][Medline]
[Order article via Infotrieve]
-
Davies, G., and Stark, G.
(1970)
Proc. Natl. Acad. Sci. U. S. A.
66,
651-656
[Abstract/Free Full Text]
-
Woodward, M. P., Young, W. W., and Bloodgood, R. A.
(1985)
J. Immunol. Methods
78,
143-153
[CrossRef][Medline]
[Order article via Infotrieve]
-
Towbin, H., Staehelin, T., and Gordon, J.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
4350-4354
[Abstract/Free Full Text]
-
Sambrook, J., Fritch, E. F., and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
-
Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J.
(1990)
J. Mol. Biol.
215,
403-410
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hata, Y., Slaughter, C. A., and Südhof, T. C.
(1993)
Nature
366,
347-351
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hosono, R., Hekimi, S., Kamiya, Y., Sassa, T., Murakami, S., Nishiwaki, K., Miwa, J., Taketo, A., and Kodaira, K. I.
(1992)
J. Neurochem.
58,
1517-1525
[CrossRef][Medline]
[Order article via Infotrieve]
-
Espinolda, F. S., Espreafico, E. M., Coelho, M. V., Martins, A. R., Costa, F., Mooseker, M. S., and Larson, R. E.
(1992)
J. Cell Biol.
118,
359-368
[Abstract/Free Full Text]
-
Burridge, K., and Bray, D.
(1975)
J. Mol. Biol.
99,
1-14
[CrossRef][Medline]
[Order article via Infotrieve]
-
Li, D., and Chantler, P. D.
(1992)
J. Neurochem.
59,
1344-1351
[Medline]
[Order article via Infotrieve]
-
Takahashi, M., Kawamoto, S., and Adelstein, R. S.
(1992)
J. Biol. Chem.
267,
17864-17871
[Abstract/Free Full Text]
-
Conrad, A. H., Jaffredo, T., and Conrad, G. W.
(1995)
Cell Motil. Cytoskeleton
31,
93-112
[CrossRef][Medline]
[Order article via Infotrieve]
-
Katsuragawa, Y., Yanagisawa, M., Inoue, A., and Masaki, T.
(1989)
Eur. J. Biochem.
184,
611-616
[Medline]
[Order article via Infotrieve]
-
Kawamoto, S., and Adelstein, R. S.
(1991)
J. Cell Biol.
112,
915-924
[Abstract/Free Full Text]
-
Simons, M., Wang, M., McBride, O. W., Sachiyo, K., Katsutoshi, Y., Gdula, D., Adelstein, R. S., and Weir, L.
(1991)
Circ. Res.
69,
531-539
-
Murakami, N., Mehta, P., and Elzinga, M.
(1991)
FEBS Lett.
278,
23-25
[CrossRef][Medline]
[Order article via Infotrieve]
-
Mooseker, M. S., and Cheney, R. E.
(1995)
Annu. Rev. Cell Dev. Biol.
11,
633-675
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hasson, T., Heintzelman, M. B., Santos-Sacchi, J., Corey, D. P., and Mooseker, M. S.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
9815-9819
[Abstract/Free Full Text]
-
Bement, W. M., Hasson, T., Wirth, J. A., Cheney, R. E., and Mooseker, M. S.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
6549-6553
[Abstract/Free Full Text]
-
D'Andrea, L., Danon, M. A., Sgourdas, G. P., and Bonder, E. M.
(1994)
J. Cell Sci.
107,
2081-2094
[Abstract]
-
Sellers, J. R., Soboeiro, M. S., Faust, K., Bengur, A. R., and Harvey, E. V.
(1988)
Biochemistry
27,
6977-6982
[CrossRef][Medline]
[Order article via Infotrieve]
-
Owaribe, K., Kartenbeck, J., Rungger-Brändle, E., and Franke, W. W.
(1988)
Cell Tissue Res.
254,
301-315
[CrossRef][Medline]
[Order article via Infotrieve]
-
Weil, D., Blanchard, S., Kaplan, J., Guilford, P., Gibson, F., Walsh, J., Mburu, P., Varela, A., Levelliers, J., Weston, M. D., Kelley, P. M., Kimberling, W. J., Wagenaar, M., Levi-Acobas, F., Larget-Piet, D., Munnich, A., Steel, K. P., Brown, S. D., and Petit, C.
(1995)
Nature
374,
60-61
[CrossRef][Medline]
[Order article via Infotrieve]
-
Alliegro, M. C., and Alliegro, M. A.
(1996)
Dev. Biol.
174,
288-297
[CrossRef][Medline]
[Order article via Infotrieve]
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Pompili, A. De Luca, S. L. Nori, B. Maras, G. De Renzis, F. Ortolani, and L. Fumagalli
Biochemical and Immunohistochemical Evidence for a Non-muscle Myosin at the Neuromuscular Junction in Bovine Skeletal Muscle
J. Histochem. Cytochem.,
April 1, 2003;
51(4):
471 - 478.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|